Plain-English translation of NCT04684602 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This clinical trial is testing a regenerative therapy using stem cells from amniotic and umbilical cord tissue to treat various chronic and acute conditions. The study is enrolling up to 5,000 patients across multiple disease categories, including autoimmune disorders, cardiovascular disease, diabetes, nerve disorders, and others. Researchers believe this treatment may be both safe and effective based on early findings and existing research.
While initial clinical observations and research suggest that stem cell therapy shows promise for treating many different diseases, more rigorous testing is needed to confirm it is truly safe and effective. This large study aims to gather solid evidence about whether the treatment works and what side effects patients might experience.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive an injection of the stem cell treatment tailored to your specific condition. You will then attend follow-up visits to allow researchers to monitor your health, check for any side effects, and measure whether the treatment is helping your condition improve. The study uses standardized assessment tools to measure both overall quality of life and specific improvements related to your disease.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States